Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab

被引：0
|
作者：
Bell, Christopher F. [1 ]
Priest, Julie [1 ,2 ,3 ]
Amelio, Justyna [4 ]
Song, Xue [5 ]
Kan, Hong [6 ]
Stott-Miller, Marni [7 ]
Limone, Brendan [5 ]
Noxon, Virginia [5 ]
Costenbader, Karen H. [8 ,9 ]
机构：
[1] GSK US Value Evidence & Outcomes, Res Triangle Pk, NC USA
[2] US Hlth Outcomes, Durham, NC USA
[3] ViiV Healthcare, Durham, NC USA
[4] GSK Real World Evidence & Epidemiol, Stevenage, Herts, England
[5] Truven Hlth Analyt, Ann Arbor, MI USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[7] GSK Real World Evidence & Epidemiol, Uxbridge, Middx, England
[8] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[9] Harvard Med Sch, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2593
引用
收藏
页数：3
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Sheikh, S. Z.
    Fox, N. L.
    Hammer, A. E.
    Struemper, H.
    Groark, J.
    Roth, D.
    Gordon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 297 - 298
  • [22] EFFICACY AND SAFETY OF BELIMUMAB FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Borba, H. H. L.
    Wiens, A.
    Correr, C. J.
    Pontarolo, R.
    VALUE IN HEALTH, 2013, 16 (07) : A725 - A726
  • [23] Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab
    Carrion-Barbera, Irene
    Carlos Salman-Monte, Tarek
    Castell, Sonia
    Castro-Dominguez, Francisco
    Ojeda, Fabiola
    Monfort, Jordi
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (03) : 150 - 152
  • [24] Short-term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
    Wu, Chunye
    Gong, Baoqi
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (11)
  • [25] Belimumab and antipneumococcal vaccination in patients with systemic lupus erythematosus
    Azoicai, Tudor
    Antoniu, Sabina
    Caruntu, Irina Draga
    Azoicai, Doina
    Antohe, Ileana
    Gavrilovici, Cristina
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (03) : 175 - 177
  • [26] Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010
    Lin, Tzu-Chieh
    Marmor, Michael F.
    Barbhaiya, Medha
    Guan, Hongshu
    Chen, Sarah K.
    Feldman, Candace H.
    Costenbader, Karen H.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (11) : 1700 - 1706
  • [27] Belimumab Therapy in Systemic Lupus Erythematosus
    Moncef Zouali
    Eugene A. Uy
    BioDrugs, 2013, 27 : 225 - 235
  • [28] Cytokine and Autoantibody Profiles During Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
    Parodis, Ioannis
    Akerstrom, Emil
    Sjowall, Christopher
    Sohrabian, Azita
    Jonsen, Andreas
    Gomez, Alvaro
    Frodlund, Martina
    Zickert, Agneta
    Bengtsson, Anders
    Ronnelid, Johan
    Gunnarsson, Iva
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [29] Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
    Parodis, Ioannis
    Akerstrom, Emil
    Sjowall, Christopher
    Sohrabian, Azita
    Jonsen, Andreas
    Gomez, Alvaro
    Frodlund, Martina
    Zickert, Agneta
    Bengtsson, Anders A.
    Roennelid, Johan
    Gunnarsson, Iva
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [30] Belimumab for systemic lupus erythematosus Reply
    Petri, Michelle A.
    LANCET, 2011, 377 (9783): : 2080 - 2081
12345